Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Elucidation of Gd(III)-Ligand and Gd(III)-Protein Complexes for Development of Gd(III) Contrast Agents Using High-Frequency EPR Spectroscopy

Award Number: F32GM159401
ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 04/01/2026
PERIOD OF PERFORMANCE END DATE: 03/31/2029

Group Awards By:

View Award Description

Elucidation of Gd(III)-Ligand and Gd(III)-Protein Complexes for Development of Gd(III) Contrast Agents Using High-Frequency EPR Spectroscopy - Project Summary /Abstract Gd3+-based contrast agent (GBCA) enables enhanced MRI images for visualizing internal organs, tissues, and blood vessels. While GBCA is primarily considered safe, trace amounts of Gd have been detected in the bones and brains of patients after multiple administration of GBCA. Additionally, a life-threatening but rare nephrogenic systemic fibrosis disease can occur in patients with chronic kidney disease after exposure to GBCA. Currently, the use of GBCA is restricted against patients who are at risk. Hence, developing a new GBCA is of high interest from the perspective of contrasting capability and safety. However, such development requires the ability to diagnose GBCA stability both in vitro and in vivo. In this proposal, we will develop a unique high-powered 263 GHz Electron Paramagnetic Resonance (EPR) spectrometer that will enable sensitive detection and highly- resolved characterization of the Gd3+ coordination environment in both test tubes and cells. The new spectrometer will be at the forefront of Gd3+-based magnetic resonance, paving the way for describing the physical chemistry of Gd3+. We will also establish the EPR spectral features associated with Gd3+ bound to its chelating carrier or dissociated Gd3+ that has interacted with endogenous proteins. Specifically, we will use a class of lanthanide-binding peptides known as Lanthanide-Binding Tag (LBT3) and a recently discovered picomolar lanthanide-binding protein, LanM, which has invigorated the field of lanthanide biochemistry. The high- frequency Gd3+ EPR spectra contain zero-field splitting features that serve as the spectral 'fingerprint' of different Gd3+-protein interactions, crucial for diagnosing either ligand-bound or protein-bound Gd3+. Finally, we will use LanM and engineered LBT3 as candidates for new GBCAs. The picomolar affinities of these proteins, which have been exploited for commercial lanthanide extraction strategies, are also highly promising for carriers of GBCA. This research plan aims to integrate EPR methodologies to gain insight into the structural features of Gd3+-ligand and Gd3+-protein interactions for future GBCA development. The long-term goal is to develop a method that can identify the different Gd3+ complexes, either to assess the stability of GBCA in a biological context or to create new GBCAs with new coordination environments. The fellowship will support the applicant in gaining expertise in microwave engineering and protein engineering, preparing him for a well-rounded career as an investigator at the front line of magnetic resonance spectroscopy and lanthanide-related structural biology.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $79,348 )
2026	2026	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR STE 300	DAVIS	CA	95618	YOLO	USA	Biomedical Research and Research Training	001	1	3/26/2026	NEW	$1,308
2026	2026	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR STE 300	DAVIS	CA	95618	YOLO	USA	Biomedical Research and Research Training	000	1	3/19/2026	NEW	$78,040
2026	2026	UNIVERSITY OF CALIFORNIA, DAVIS	1850 RESEARCH PARK DR STE 300	DAVIS	CA	95618	YOLO	USA	Biomedical Research and Research Training	002	1	3/26/2026	NEW	$0
														Subtotal = $79,348

Grand Total All Awards = $79,348

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Elucidation of Gd(III)-Ligand and Gd(III)-Protein Complexes for Development of Gd(III) Contrast Agents Using High-Frequency EPR Spectroscopy

Award Number: F32GM159401

ORGANIZATION: NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 04/01/2026

PERIOD OF PERFORMANCE END DATE: 03/31/2029

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer